APO Research

APO RESEARCH · REPORT

Companion Animals Rabies Veterinary Vaccines

Selected research

Market Outlook & Growth Opportunities

Global Companion Animals Rabies Veterinary Vaccines Market Outlook and Growth Opportunities 2026

Market perspective

The global Companion Animals Rabies Veterinary Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Companion Animals Rabies Veterinary Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animals Rabies Veterinary Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animals Rabies Veterinary Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Companion Animals Rabies Veterinary Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Companion Animals Rabies Veterinary Vaccines market include Zoetis, Tianjin Ringpu Bio-Technology, Merck & Co., Inc., Virbac, Indian Immunologicals Ltd., Elanco, Dyntec, Ceva and BroadChem Philippines Biopharma Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Companion Animals Rabies Veterinary Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animals Rabies Veterinary Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animals Rabies Veterinary Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animals Rabies Veterinary Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animals Rabies Veterinary Vaccines Segment by Company

Zoetis

Tianjin Ringpu Bio-Technology

Merck & Co., Inc.

Virbac

Indian Immunologicals Ltd.

Elanco

Dyntec

Ceva

BroadChem Philippines Biopharma Corporation

Boehringer Ingelheim International GmbH

BiogenesisBago

Companion Animals Rabies Veterinary Vaccines Segment by Type

Inject Rabies Vaccine

Oral Rabies Vaccine

Companion Animals Rabies Veterinary Vaccines Segment by Application

Pet Hospital

Pet Shop

Others

Companion Animals Rabies Veterinary Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Companion Animals Rabies Veterinary Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Companion Animals Rabies Veterinary Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Companion Animals Rabies Veterinary Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Companion Animals Rabies Veterinary Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animals Rabies Veterinary Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animals Rabies Veterinary Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animals Rabies Veterinary Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Companion Animals Rabies Veterinary Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animals Rabies Veterinary Vaccines industry.

Chapter 3: Detailed analysis of Companion Animals Rabies Veterinary Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Companion Animals Rabies Veterinary Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Companion Animals Rabies Veterinary Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Companion Animals Rabies Veterinary Vaccines Industry Trends Table 2. Companion Animals Rabies Veterinary Vaccines Industry Drivers Table 3. Companion Animals Rabies Veterinary Vaccines Industry Opportunities and Challenges Table 4. Companion Animals Rabies Veterinary Vaccines Industry Restraints Table 5. Global Companion Animals Rabies Veterinary Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Companion Animals Rabies Veterinary Vaccines Revenue Share by Company (2021-2026) Table 7. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Company (k units) & (2021-2026) Table 8. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Companion Animals Rabies Veterinary Vaccines Average Price (US$/unit) of Company (2021-2026) Table 10. Global Companion Animals Rabies Veterinary Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Companion Animals Rabies Veterinary Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Companion Animals Rabies Veterinary Vaccines Company, Product Type & Application Table 13. Global Companion Animals Rabies Veterinary Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Companion Animals Rabies Veterinary Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inject Rabies Vaccine Table 18. Significant Companies of Oral Rabies Vaccine Table 19. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type (2021-2026) & (k units) Table 21. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type (2027-2032) & (k units) Table 22. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pet Hospital Table 30. Significant Companies of Pet Shop Table 31. Significant Companies of Others Table 32. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application (2021-2026) & (k units) Table 34. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application (2027-2032) & (k units) Table 35. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application (2021-2026) Table 41. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application (2027-2032) Table 42. Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Companion Animals Rabies Veterinary Vaccines Sales by Region (2021-2026) & (k units) Table 44. Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Companion Animals Rabies Veterinary Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Region (2027-2032) Table 47. Global Companion Animals Rabies Veterinary Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Region (2021-2026) Table 50. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Region (2027-2032) Table 52. Global Companion Animals Rabies Veterinary Vaccines Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Companion Animals Rabies Veterinary Vaccines Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Companion Animals Rabies Veterinary Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2026) & (k units) Table 57. Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Country (2021-2026) Table 58. Global Companion Animals Rabies Veterinary Vaccines Sales by Country (2027-2032) & (k units) Table 59. Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Country (2027-2032) Table 60. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Companion Animals Rabies Veterinary Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Companion Animals Rabies Veterinary Vaccines Sales Value Market Share by Country (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Zoetis Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 68. Zoetis Recent Development Table 69. Tianjin Ringpu Bio-Technology Company Information Table 70. Tianjin Ringpu Bio-Technology Business Overview Table 71. Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 73. Tianjin Ringpu Bio-Technology Recent Development Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. Virbac Company Information Table 80. Virbac Business Overview Table 81. Virbac Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Virbac Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 83. Virbac Recent Development Table 84. Indian Immunologicals Ltd. Company Information Table 85. Indian Immunologicals Ltd. Business Overview Table 86. Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 88. Indian Immunologicals Ltd. Recent Development Table 89. Elanco Company Information Table 90. Elanco Business Overview Table 91. Elanco Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Elanco Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 93. Elanco Recent Development Table 94. Dyntec Company Information Table 95. Dyntec Business Overview Table 96. Dyntec Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Dyntec Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 98. Dyntec Recent Development Table 99. Ceva Company Information Table 100. Ceva Business Overview Table 101. Ceva Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Ceva Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 103. Ceva Recent Development Table 104. BroadChem Philippines Biopharma Corporation Company Information Table 105. BroadChem Philippines Biopharma Corporation Business Overview Table 106. BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 108. BroadChem Philippines Biopharma Corporation Recent Development Table 109. Boehringer Ingelheim International GmbH Company Information Table 110. Boehringer Ingelheim International GmbH Business Overview Table 111. Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 113. Boehringer Ingelheim International GmbH Recent Development Table 114. BiogenesisBago Company Information Table 115. BiogenesisBago Business Overview Table 116. BiogenesisBago Companion Animals Rabies Veterinary Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. BiogenesisBago Companion Animals Rabies Veterinary Vaccines Product Portfolio Table 118. BiogenesisBago Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Companion Animals Rabies Veterinary Vaccines Distributors List Table 122. Companion Animals Rabies Veterinary Vaccines Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Companion Animals Rabies Veterinary Vaccines Product Image Figure 2. Global Companion Animals Rabies Veterinary Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Companion Animals Rabies Veterinary Vaccines Sales (2021-2032) & (k units) Figure 5. Global Companion Animals Rabies Veterinary Vaccines Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Companion Animals Rabies Veterinary Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inject Rabies Vaccine Image Figure 10. Oral Rabies Vaccine Image Figure 11. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type (2021-2032) Figure 17. Pet Hospital Image Figure 18. Pet Shop Image Figure 19. Others Image Figure 20. Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Companion Animals Rabies Veterinary Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Companion Animals Rabies Veterinary Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Companion Animals Rabies Veterinary Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Companion Animals Rabies Veterinary Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Rabies Vaccine
  • Oral Rabies Vaccine
Applications
  • Pet Hospital
  • Pet Shop
  • Others
Companies covered
  • Zoetis
  • Tianjin Ringpu Bio-Technology
  • Merck & Co., Inc.
  • Virbac
  • Indian Immunologicals Ltd.
  • Elanco
  • Dyntec
  • Ceva
  • BroadChem Philippines Biopharma Corporation
  • Boehringer Ingelheim International GmbH
  • BiogenesisBago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Companion Animals Rabies Veterinary Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Companion Animals Rabies Veterinary Vaccines Market Dynamics
  1. 2.1 Companion Animals Rabies Veterinary Vaccines Industry Trends
  2. 2.2 Companion Animals Rabies Veterinary Vaccines Industry Drivers
  3. 2.3 Companion Animals Rabies Veterinary Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animals Rabies Veterinary Vaccines Industry Restraints
3 Companion Animals Rabies Veterinary Vaccines Market by Company
  1. 3.1 Global Companion Animals Rabies Veterinary Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Companion Animals Rabies Veterinary Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Companion Animals Rabies Veterinary Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Companion Animals Rabies Veterinary Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Companion Animals Rabies Veterinary Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Companion Animals Rabies Veterinary Vaccines Company Product Type and Application
  8. 3.8 Global Companion Animals Rabies Veterinary Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Companion Animals Rabies Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Companion Animals Rabies Veterinary Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Companion Animals Rabies Veterinary Vaccines Market by Type
  1. 4.1 Companion Animals Rabies Veterinary Vaccines Type Introduction
  2. 4.1.1 Inject Rabies Vaccine
  3. 4.1.2 Oral Rabies Vaccine
  4. 4.2 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type
  5. 4.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type
  9. 4.3.1 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type (2021-2032)
5 Companion Animals Rabies Veterinary Vaccines Market by Application
  1. 5.1 Companion Animals Rabies Veterinary Vaccines Application Introduction
  2. 5.1.1 Pet Hospital
  3. 5.1.2 Pet Shop
  4. 5.1.3 Others
  5. 5.2 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application
  6. 5.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Companion Animals Rabies Veterinary Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application
  10. 5.3.1 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application (2021-2032)
6 Companion Animals Rabies Veterinary Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animals Rabies Veterinary Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Companion Animals Rabies Veterinary Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Companion Animals Rabies Veterinary Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Companion Animals Rabies Veterinary Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Companion Animals Rabies Veterinary Vaccines Sales Value Share by Country, 2025 VS 2032
7 Companion Animals Rabies Veterinary Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Companion Animals Rabies Veterinary Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Companion Animals Rabies Veterinary Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Companion Animals Rabies Veterinary Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Companion Animals Rabies Veterinary Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Companion Animals Rabies Veterinary Vaccines Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Tianjin Ringpu Bio-Technology
  8. 8.2.1 Tianjin Ringpu Bio-Technology Company Information
  9. 8.2.2 Tianjin Ringpu Bio-Technology Business Overview
  10. 8.2.3 Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Ringpu Bio-Technology Companion Animals Rabies Veterinary Vaccines Product Portfolio
  12. 8.2.5 Tianjin Ringpu Bio-Technology Recent Developments
  13. 8.3 Merck & Co., Inc.
  14. 8.3.1 Merck & Co., Inc. Company Information
  15. 8.3.2 Merck & Co., Inc. Business Overview
  16. 8.3.3 Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co., Inc. Companion Animals Rabies Veterinary Vaccines Product Portfolio
  18. 8.3.5 Merck & Co., Inc. Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Companion Animals Rabies Veterinary Vaccines Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Indian Immunologicals Ltd.
  26. 8.5.1 Indian Immunologicals Ltd. Company Information
  27. 8.5.2 Indian Immunologicals Ltd. Business Overview
  28. 8.5.3 Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Indian Immunologicals Ltd. Companion Animals Rabies Veterinary Vaccines Product Portfolio
  30. 8.5.5 Indian Immunologicals Ltd. Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Companion Animals Rabies Veterinary Vaccines Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Dyntec
  38. 8.7.1 Dyntec Company Information
  39. 8.7.2 Dyntec Business Overview
  40. 8.7.3 Dyntec Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dyntec Companion Animals Rabies Veterinary Vaccines Product Portfolio
  42. 8.7.5 Dyntec Recent Developments
  43. 8.8 Ceva
  44. 8.8.1 Ceva Company Information
  45. 8.8.2 Ceva Business Overview
  46. 8.8.3 Ceva Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Companion Animals Rabies Veterinary Vaccines Product Portfolio
  48. 8.8.5 Ceva Recent Developments
  49. 8.9 BroadChem Philippines Biopharma Corporation
  50. 8.9.1 BroadChem Philippines Biopharma Corporation Company Information
  51. 8.9.2 BroadChem Philippines Biopharma Corporation Business Overview
  52. 8.9.3 BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BroadChem Philippines Biopharma Corporation Companion Animals Rabies Veterinary Vaccines Product Portfolio
  54. 8.9.5 BroadChem Philippines Biopharma Corporation Recent Developments
  55. 8.10 Boehringer Ingelheim International GmbH
  56. 8.10.1 Boehringer Ingelheim International GmbH Company Information
  57. 8.10.2 Boehringer Ingelheim International GmbH Business Overview
  58. 8.10.3 Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim International GmbH Companion Animals Rabies Veterinary Vaccines Product Portfolio
  60. 8.10.5 Boehringer Ingelheim International GmbH Recent Developments
  61. 8.11 BiogenesisBago
  62. 8.11.1 BiogenesisBago Company Information
  63. 8.11.2 BiogenesisBago Business Overview
  64. 8.11.3 BiogenesisBago Companion Animals Rabies Veterinary Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BiogenesisBago Companion Animals Rabies Veterinary Vaccines Product Portfolio
  66. 8.11.5 BiogenesisBago Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Companion Animals Rabies Veterinary Vaccines Value Chain Analysis
  2. 9.1.1 Companion Animals Rabies Veterinary Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Companion Animals Rabies Veterinary Vaccines Sales Mode & Process
  6. 9.2 Companion Animals Rabies Veterinary Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Companion Animals Rabies Veterinary Vaccines Distributors
  9. 9.2.3 Companion Animals Rabies Veterinary Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research